Reaction
Hydroureter reporting signals
As of the last recalculation, Hydroureter appears in 370 FAERS reports alongside 8 co-occurring drug terms. The strongest observed disproportionality signal is POLATUZUMAB VEDOTIN (PRR 71.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Polatuzumab Vedotin | 12 | 71.5 | 71.5 |
| Bicalutamide | 14 | 53.7 | 53.7 |
| Icosapent Ethyl | 6 | 40.3 | 40.3 |
| Abiraterone | 8 | 33.8 | 33.8 |
| Obinutuzumab | 9 | 31.5 | 31.5 |
| Panitumumab | 6 | 21.9 | 21.9 |
| Abiraterone Acetate | 11 | 15.5 | 15.5 |
| Enzalutamide | 13 | 12.9 | 12.9 |